Infectious disease
SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01) LQLPQGTTL
€106.60*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP14600_1
Description
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The nucleocapsid protein has different functions in the coronavirus replication cycle. SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01) is a linear peptidic epitope studied as part of nucleoprotein from severe acute respiratory syndrome-related coronavirus. This peptide has been tested for immune reactivity in T cell assays and MHC ligand assays.
TechData
| Sequence: | LQLPQGTTL |
| Gene: | N |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Nucleoprotein |
| Species: | SARS-CoV-2 |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |